The European Commission for the Control of Foot-and-Mouth Disease (EuFMD)

Food and Agriculture Organization of the United Nations
European Commision

Vaccinology

Aim

  • To explore innovative technological platforms for FAST vaccines, to identify options for their development and commercialization and to better understand their advantages and limitations compared to conventional vaccines; to identify innovative developments and digitalization applied to cold chain logistics and vaccine monitoring; to examine a real-life example of innovative vaccine projects to capture best practice principles that can be translated to other regional projects.

Main issues

  • Innovative platform-based technologies offer real hope for the accelerated development of FAST vaccines that can be quickly and easily modified to combat evolving field strains. What are the most suitable technology platforms currently for priority FAST diseases?
  • Innovative platform-based technologies offer many potential advantages over conventional vaccines. However, for any novel vaccine technology, there are also limitations to its application in the control of FAST diseases. How can we balance the advantages and limitations of each vaccine platform to direct research efforts towards the optimum technology for each FAST disease?
  • How can the veterinary sector translate the experience gained with the development and commercialization of COVID-19 vaccines to fast-track similar development and commercialization of innovative technology platforms of FAST vaccines?
  • What are the take home messages from projects (e.g., AgResults Foot and Mouth Disease Vaccine Challenge Project) aimed at encouraging the development and uptake of high-quality FMD vaccines tailored to meet the regional needs and how can we capture the best practices to establish similar schemes on other regions of the world?
  • Are there innovative developments in cold chain logistics that can help improve the distribution and monitoring of FAST vaccines from the manufacturing site to the field to ensure the quality of the vaccine at the point of administration?
  • What innovative developments in vaccination monitoring can help improve the management of FAST disease outbreaks?